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Abstract
Background: We describe human rhinovirus (HRV) detections in SaKaeo province, Thailand.
Methods: From September 1, 2003–August 31, 2005, we tested hospitalized patients with acute lower respiratory illness
and outpatient controls without fever or respiratory symptoms for HRVs with polymerase chain reaction and molecularly-
typed select HRVs. We compared HRV detection among hospitalized patients and controls and estimated enrollment
adjusted incidence.
Results: HRVs were detected in 315 (16%) of 1919 hospitalized patients and 27 (9.6%) of 280 controls. Children had the
highest frequency of HRV detections (hospitalized: ,1 year: 29%, 1–4 year: 29%, $65 years: 9%; controls: ,1 year: 24%, 1–4
year: 14%, $65 years: 2.8%). Enrollment adjusted hospitalized HRV detection rates were highest among persons aged ,1
year (1038/100,000 persons/year), 1–4 years (457), and $65 years (71). All three HRV species were identified, HRV-A was the
most common species in most age groups including children aged ,1 year (61%) and all adult age groups. HRV-C was the
most common species in the 1–4 year (51%) and 5–19 year age groups (54%). Compared to controls, hospitalized adults
($19 years) and children were more likely to have HRV detections (odds ratio [OR]: 4.8, 95% confidence interval [CI]: 1.5,
15.8; OR: 2.0, CI: 1.2, 3.3, respectively) and hospitalized children were more likely to have HRV-A (OR 1.7, CI: 0.8, 3.5) or HVR-C
(OR 2.7, CI: 1.2, 5.9) detection.
Conclusions: HRV rates were high among hospitalized children and the elderly but asymptomatic children also had
substantial HRV detection. HRV (all species), and HRV-A and HRV-C detections were epidemiologically-associated with
hospitalized illness. Treatment or prevention modalities effective against HRV could reduce hospitalizations due to HRV in
Thailand.
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Introduction
Human rhinoviruses (HRVs) are members of the family
Picornaviridae, genus Enterovirus, and comprise 3 species, HRV-A,
HRV-B and the recently recognized HRV-C [1,2,3]. HRVs are a
well established cause of the common cold, an upper respiratory
illness characterized by rhinorrhea, nasal congestion, cough, sore
throat and sneezing; more than half of upper respiratory illnesses
are caused by HRVs [4]. Recently, several studies have suggested
that HRVs may be associated with more severe illness, including
hospitalized lower respiratory disease and asthma exacerbations
[5,6] [7,8,9,10,11,12,13,14,15]. Also, some studies suggest that
infection with HRV-C may result in more severe illness compared
to illness with other species [1,2,16,17].
HRVs have also been identified among asymptomatic persons
(detection in the nasopharynx in the absence of respiratory
symptoms) as an innocent ‘‘bystander virus’’ [18]. The reported
prevalence of HRV detection among asymptomatic persons
ranges from 12–22% among children and 9% among adults with
immunocompromising conditions [19,20,21,22]. Consequently,
the clinical relevance of detection of HRV among hospitalized
patients can be difficult to interpret and better studies are needed
to ascertain the role of HRVs as pathogens to spur efforts to
develop treatment and prevention modalities. To that end, we
took advantage of a study in rural Thailand that concurrently
enrolled hospitalized patients with acute lower respiratory illness, a
sample of outpatients with influenza-like illness, and control
outpatients without fever or respiratory symptoms from the same
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17780hospitals to better define the etiologic role of HRV infection and
associated disease burden in this community.
Methods
The surveillance system and laboratory procedures have been
published previously [23]. Briefly, residents of Sa Kaeo province,
Thailand who were identified in active population-based surveil-
lance for hospitalized acute respiratory illness were approached for
enrollment into a pneumonia etiology study during September 1,
2003 through August 31, 2005. Enrollment occurred in all 8
hospitals in Sa Kaeo province. A patient was eligible for
enrollment if he/she had at least one sign of acute infection (e.g.
fever, abnormal white blood cell count) plus signs or symptoms of
lower respiratory tract disease (e.g. cough, abnormal breath
sounds) and the physician ordered a chest radiograph within
48 hours of admission. Each enrolled patient had a nasopharyn-
geal swab, acute and convalescent serum, and demographic
information collected. We considered repeat hospitalizations that
occurred $14 days after the previous discharge date as individual
hospitalizations. Chest radiographs were read by an expert panel
as described previously [24].
In addition, a convenience sample of outpatients with influenza-
like illness (fever plus cough or sore throat) was recruited from the
outpatient departments from the same hospitals in Sa Kaeo
Province during the study period [25]; 8 outpatient departments
participated during year one and 5 departments participated
during the following year. Each outpatient participant had a
nasopharyngeal swab and demographic information collected.
During the second study year, September 1, 2004–August 31,
2005, we collected nasopharyngeal swabs and demographic
information from control outpatients (i.e., patients who did not
have a fever, and did not report a fever, cough, sore throat or
diarrhea within the previous 3 days) from the outpatient clinics as
described above. We sought to enroll the same number of controls
from five age groups (#2 yrs, 3–5 yrs, 6–15 yrs, 16–54 yrs, and
$55 yrs) during each month of the year, (median number/month
for all controls=25, range 10–30).
The processing and testing of nasopharyngeal swabs were
described elsewhere and included individual PCR assays for each
pathogen and viral isolation for some viruses [23]. All specimens
were tested by a laboratory blinded to patient status, e.g.,
hospitalized, outpatient, or control. Nasopharyngeal specimens
were tested for respiratory syncytial virus (RSV), human
metapneumovirus (HMPV), human parainfluenza viruses (HPIVs)
1, 2, and 3, influenza viruses A and B, adenovirus, Legionella
species, Chlamydia pneumoniae, and Mycoplasma pneumonia, and
rhinovirus/enterovirus (Table S1). HRV was detected from
respiratory specimens by first testing with RT-PCR primers to
detect rhinovirus/enterovirus as described in Roghmann, et al
[26]. To discriminate between HRVs and human enteroviruses,
PCR positive samples were retrospectively subjected to a second
round of semi-nested PCR using HRV-specific primers as
described in Miller, et al. [11]. Viral isolation was performed for
RSV, HPIV, influenza viruses and adenovirus. Paired sera was
tested for RSV, HMPV, HPIV 1,2 and 3, adenovirus, influenza,
Legionella sp., Chlamydia penumoniae, and Mycoplasma pneumoniae as
described [23,27]. For HRV, a positive RT-PCR result was
considered a positive result. For other pathogens, a positive
culture, RT-PCR, or four-fold rise in serology was considered a
positive test result. Serologic testing and PCR assays for Legionella
sp., Chlamydia penumoniae, and Mycoplasma pneumoniae were only
performed on patients enrolled during the first study year,
September 2003–August 31, 2004 and interpreted as previously
described [27]. In addition, diagnostic testing included urine
pneumococcal surface antigen assay among pneumonia patients
aged $18 years. HRV positive samples from hospitalized and
control patients during September 1, 2004 through August 31,
2005 were further identified to species by RT-PCR and
sequencing of partial region of the VP1 (D. Erdman, unpublished,
method available on request). Specimens that were VP1 negative
were further tested using primers that amplified partial VP4/VP2
or 59NCR regions [28].
We calculated crude and age-specific (,1, 1–4, 5–19, 20–49,
50–64, $65 years) incidence for hospitalized HRV infections using
population estimates from Thailand’s National Economic and
Social Development Board for the period January 1, 2003 through
December 31, 2005 [29]. Because not all patients eligible for our
study were enrolled, we estimated adjusted incidence to account
for eligible patients who did not enroll. For the adjusted incidence
we assumed the proportion of HRV detections in the enrolled
patients was the same as the proportion of infections among all
eligible patients.
To determine whether HRV detections were epidemiologically
associated with hospitalized respiratory illness, we compared HRV
detections among hospitalized enrolled patients to detections
among control patients without fever or respiratory symptoms.
Because controls were collected from the second study year,
September 1, 2004–August 31, 2005, this comparison was limited
to hospitalized patients from the same year. Two-tailed P values of
,0.05 were considered to be statistically significant.
All participants were informed of the study objectives and
written consent was obtained. This study protocol was reviewed
and approved by the Centers for Disease Control and Prevention
(CDC) Internal Review Board and the Thailand Ministry of Public
Health Internal Review Board.
Results
From September 1, 2003 to August 31, 2005, 7449 patients with
signs and symptoms of acute lower respiratory tract infection were
admitted to hospital in Sa Kaeo province and 4347 (58%) of these
patients had a chest radiograph ordered within 48 hours. We
enrolled 1941 (45%) of the eligible hospitalized patients (e.g. with
acute lower respiratory illness and a chest radiograph). Among all
eligible patients, those who were and were not enrolled had similar
presenting signs and symptoms (data not shown), intubation (4.2%
vs. 5%), and fatalities (4% vs. 5.2%), respectively. However,
persons who were enrolled were older compared to those not
enrolled (median age 40 years (interquartile range (IQR): 3–67
years) versus 20 years (IQR: 2–63 years), respectively). In addition,
we enrolled a sample of 1569 outpatients with influenza-like
illness. During the second year of the study, we enrolled 280
control patients.
We detected HRVs in 16% of hospitalized enrolled patients
(overall and with radiographically-confirmed pneumonia), 19% of
outpatients with influenza-like illness, and 9.6% of control patients
(Table 1). The frequency of HRV detection was highest among
enrolled patients #19 years of age, especially young children aged
,5 years. However, a substantial proportion of hospitalized adult
patients in all age groups had HRVs detected. Among adults .20
years of age with radiographically-confirmed pneumonia, 7.9%
had HRV detection. Among all patients with radiographically-
confirmed pneumonia, 16% had HRV detection. The proportion
of HRV positive control patients was highest among the youngest
children; 4 (14%) of 28 infants aged 0–6 months and 4 (67%) of 6
infants aged 6–11 months had HRV detections. Among all
patients, HRV detections were statistically more common among
Rhinovirus Detections in Thailand
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there were differences in the association between hospitalization
and HRV detection when stratified by age group, evidence for
effect modification by age.
The adjusted incidence rates of HRV detections among
hospitalized patients with lower respiratory tract illness were
highest among children ,1 year, children 1–4 years, and adults
$65 years of age (Table 2). Rates were high even after excluding
patient with co-detections with other respiratory pathogens.
Young children and elderly adults also had high rates of
radiographically-confirmed pneumonia. Rates of hospitalized
enrolled adults from Sa Kaeo province aged .50 years with
HRV detections and lower respiratory tract illness and radio-
graphically-confirmed pneumonia have been published previously
(enrolled patients with [89/100,000] and without co-detection of
another pathogen [78/100,000]; radiographically-confirmed
pneumonia with [51/100,000] and without co-detection of
another pathogen [39/100,000]) [23].
HRV co-detections with other respiratory pathogens were
common among all age groups, but most striking among young
children (Table 3). Among hospitalized enrolled patients with
HRV detection: 30 (9.5%) were co-infected with RSV, 19 (3.5%)
with HPIV, 16 (6.0%) with influenza A or B, 5 (1.6%) with HMPV
and 20 (6.3%) with adenoviruses. Co-detection of pathogens for
each age-group is detailed elsewhere
23. Among 306 hospitalized
HRV positive adults aged $18 years 15 (4.9%) had co-detection of
S. pneumonia. During the first study year, eight (6.8%) of 117
patients with HRV had co-detection of an atypical bacterial
pathogen [27], one adult with L. longbeacheae, two patients with M.
pneumoniae, and five patients with co-detection of Chlamydia
pneumoniae. Among outpatients with influenza-like illness and
HRV detection: 7 (2.3%) were co-infected with RSV, 14 (4.6%)
Table 1. Comparison of HRV detections among hospitalized patient with lower respiratory tract infections, outpatients with
influenza-like illness and controls
£ without respiratory symptoms and fever in the previous 3 days, Sa Kaeo Province, Thailand,
September 1, 2003–August 31, 2005.
Age groups
Hospitalized Enrolled
HRV+/Total enrolled
(%)
Hospitalized CXR
Pneumonia
HRV+/Total CXR
pneumonia (%)
Outpatients with ILI
HRV+/Total enrolled
(%)
Controls
*
HRV+/Total enrolled
(%) OR
£ (95% CI)
0–11 mo 47/164 (29) 21/103 (20) 27/95 (28) 8/34 (24) 1.4 (0.6, 3.4)
1–4 yrs 105/366(29) 69/249 (28) 145/594 (24) 7/51 (14) 2.3 (1.0, 5.2)
1
5–19 yrs 37/182 (20) 20/80 (25) 103/706 (15) 9/69 (13) 1.8 (0.8, 4.0)
20–49 yrs 47/406 (11) 25/237 (11) 13/112 (12) 2/54 (3.7) 3.3 (0.8, 14.5)
50–64 yrs 32/273 (12) 20/172 (12) 4/41 (9.8) 0/36
1
$65 yrs 47/545 (9) 25/317 (8.0) 2/21 (9.5) 1/36 (2.8) 2.9 (0.4, 22.0)
Total 315/1936 (16) 180/1158 (16) 294/1569 (19) 27/280 (9.6) 1.9 (1.2, 2.9)
1
HRV=human rhinovirus, CXR=chest radiograph-confirmed, ILI=influenza-like illness, OR=crude odds ratio.
*Control patients were only enrolled during year two, Sept 1, 2004–Aug 31, 2005.
£Hospitalized enrolled patients from year two, Sept 1, 2004–Aug 31, 2005, were compared to controls. The number of hospitalized patients with HRV detection during
year two were 1–11 months: 31/103 (30%), 1–4 years: 73/276 (26%), 5–19 years: 26/125 (21%), 20–49 years (24/212 (11%), 50–64 years: 21/156 (13%), $65 years: 23/302
(7.6%). The results were similar with age groups stratified by #2 yrs (OR=1.8, 95% CI 0.89, 3.8, p=.09), 3–5 yrs (OR=1.2, 95% CI 0.42, 3.2, p=.75), 6–15 yrs (OR=2.0,
95% CI 0.84, 4.9, p=.11), 16–54 yrs (OR=4.0, 95% CI 0.94, 17.3, p=.04), and $55 yrs (OR=6.7, 95% CI 0.90, 49.7, p=.03).
1X
2P#.05.
doi:10.1371/journal.pone.0017780.t001
Table 2. Crude and enrollment adjusted age group specific incidence* for hospitalized HRV detections, Sa Kaeo Province, Sept 1,
2003–Aug 31, 2005.
Hospitalized Enrolled Hospitalized CXR Pneumonia
Age groups Crude
Adjusted for
enrollment
Adjusted, excluding
co-detections** Crude Adjusted for enrollment
Adjusted, excluding
co-detections**
0–11 mo 323 1038 574 145 464 265
1–4 yrs 173 457 277 115 303 189
5–19 yrs 13 29 21 6.9 16 12
20–49 yrs 9.5 21 18 5.2 12 10
50–64 yrs 25 53 36 16 33 21
.65 yrs 75 159 139 40 85 74
Total 30 71 49 17 41 29
HRV=human rhinovirus, CXR=chest radiograph-confirmed,
*Rate/100,000 persons/year.
**Co-detections included RSV, HMPV, HPIV 1–3, influenza type A or B, and adenovirus for all patients, and S. pneumoniae for adults aged $18 years. During the first
study year, co-detections with Mycoplasma, Chlamydia,a n dLegionella were excluded.
doi:10.1371/journal.pone.0017780.t002
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with HMPV, and 16 (5.3%) with adenoviruses. Among controls,
one had co-detection of HPIV-2 and one with adenovirus.
All three HRV species were identified from the 225 HRV-
positive specimens from the control and hospitalized patients
enrolled during the second year of the study (Table 4); no
statistically significant differences in the proportion of individual
species between controls and hospitalized patients were found.
HRV-A was the most common species in most age groups
including children aged ,1 year and all adult age groups. HRV-C
was the most common species in the 1–4 year and 5–19 year age
groups. Among hospitalized patients, co-detection of other
respiratory pathogens did not vary by HRV species (HRV without
co-detection: HRV-A: 56 [70%], HRV-B: 20 [77%], HRV-C: 48
[67%]) or by the presence of radiographically-confirmed pneu-
monia (HRV-A: 37 [46%], HRV-B: 14 [54%], HRV-C: 38
[52%]).
We compared HRV detection among hospitalized patients and
controls stratified into two groups, adult and children, due to
possible effect modification by age (Table 5). After adjusting for
month of detection, HRV detections were statistically more
common among hospitalized enrolled adults and children com-
pared to controls, the association was 2-fold elevated among adults.
The association with hospitalization persisted when patients with
co-detection of other respiratory pathogens were excluded.
Detection of HRV- A and HRV-C, when other respiratory
pathogen co-detections were excluded, were statistically associated
with hospitalization among children. The risk of HRV- A and
HRV-C detections among hospitalized adults compared to controls
was elevated but not statistically significant. The associations were
unchanged when we did not adjust for month of detection.
We looked for clinical evidence that co-detection of HRV with
RSV might be similar to clinical illness associated with RSV and
be different than illness associated with HRV only detections. We
found no difference in clinical symptoms at the time of hospital
admission among children aged ,5 years with either RSV-HRV
co-detection, RSV only, or HRV only detection, including
frequency of fever, tachypnea, abnormal breath sounds and
cough, and no differences in the proportion of children receiving
mechanical ventilation or supplemental oxygen use (data not
shown). However, children with HRV detection had fewer
radiographically-confirmed pneumonias compared to patients
with RSV detections (RSV: 100/135 [74%], HRV: 72/124
[58%], p,.05). There were no differences between RSV-HRV co-
detections (18/28 [64%] and RSV or HRV alone. Five patients
with HRV detected died while hospitalized during the study
period; three were $65 years of age and none had co-detection of
another respiratory pathogen.
We found no differences in clinical characteristics among
hospitalized enrolled patients with HRV-A, -B or -C detections,
including cough (A: 68/79 [85%], B: 21/26 [81%], C: 67/70
[96%]), temperature $38.2uC at admission (A: 47/79 [59%], B:
17/26 [65%], C: 36/71 [51%]), age-specific tachypnea (A: 15/78
[19%],B: 4/24 [17%],C: 14/68 [21%]), wheezing (A: 22/79
[28%], B: 9/26 [35%], C; 23/68 [34%]), elevated white blood cell
count (.11,000) (A: 50/78 [64%], B: 15/26 [58%], C; 48/67
[72%]), ventilator use (A:3/78 [3.8%], B: 0/24,C; 2/72 [2.7%]),
or in hospital deaths (A: 3/78 [3.7%], B: 1/26 [3.9%], C: 0/73).
HRVs were detected during all months of the year among all
enrolled ill patients, including outpatients with influenza-like
Table 3. Patients with HRV detection and co-detection of other respiratory pathogens*, Sa Kaeo Province, Thailand, September 1,
2003–August 31, 2005.
Age groups Hospitalized Enrolled
Hospitalized CXR pneumonia
Co-detections/HRV+ (%)
Outpatients with ILI
Co-detections/HRV+ (%)
Controls
£
Co-detections/HRV+ (%)
1–11 mo 21/47 (45) 8/21 (43) 2/27 (11) 1/8 (13)
1–4 yrs 42/105 (40) 26/68 (38) 51/145 (35) 1/7 (14)
5–19 yrs 10/37 (27) 5/18 (28) 32/103 (31) 0/9
20–49 yrs 9/47 (19) 3/25 (12) 0/13 0/2
50–64 yrs 10/32 (31) 7/20 (35) 0/4 0
$65 yrs 6/47 (13) 3/25 (12) 0/2 0/1
Total
£ 98/315 (31) 53/177 (30) 86/294 (29) 2/27 (7.4)
HRV=human rhinovirus, CXR=chest radiograph-confirmed, ILI=influenza-like illness.
*Co-detections included RSV, HMPV, HPIV 1–3, influenza type A or B, and adenovirus for all patients, and S. pneumoniae for hospitalized adults aged $18 years. During
the first study year, co-detections with Mycoplasma, Chlamydia,a n dLegionella were included for hospitalized patients.
£Control patients were only enrolled during the second study year, Sept 1, 2004–Aug 31, 2005.
doi:10.1371/journal.pone.0017780.t003
Table 4. HRV species identified among hospitalized enrolled
patients and controls
£, Sa Kaeo province, Thailand, September
1, 2004–August 31, 2005 (n=229).
Patients with HRV Species
A B C Other**
Controls (n=27), No. (%) 11(41) 5 (19) 9 (33) 2 (7.4)
Hospitalized (n=198) 80 (40) 26 (13) 73 (37) 19 (10)
Hospitalized, by age group
1–11 mo (n=31) 19 (61) 1 (3.2) 7 (23) 4 (13)
1–4 yrs (n=73) 25 (34) 3 (4.2) 37 (51) 8 (11)
5–19 yrs (n=26) 5 (19) 3 (12) 14 (54) 4 (15)
20–49 yrs (n=24) 12 (50) 6 (26) 5 (22) 1(4.2)
50–64 yrs (n=21) 9 (43) 4 (19) 7 (33) 1 (4.8)
$65 yrs (n=23) 10 (43) 9 (39) 3 (13) 1 (4.4)
HRV=human rhinovirus.
£Outpatients without respiratory symptoms and fever in the previous 3 days.
*X
2 P=.001 comparing species across age groups.
**Species not identified.
doi:10.1371/journal.pone.0017780.t004
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tract illness, with some decrease in detections during the hot and
dry months of April and May (Figure 1). HRV-A, -B and -C
appeared to circulate concurrently with no clear temporal
predominance of one species (data not shown).
Discussion
We report a high proportion of HRV detections among
hospitalized patients of all age groups in rural Thailand and
evidence that HRV detections were epidemiologically associated
with hospitalized lower respiratory tract disease among both
children and adults. In addition, both HRV-A and HRV-C were
common among hospitalized patients. Children aged ,1 year and
1–4 years and adults $65 years of age had the highest rates of
hospitalized HRV- associated acute lower respiratory illness and
pneumonia.
We detected both HRV-A and HRV-C among hospitalized
patients. Among children, both HRV-A and HRV-C detections
were epidemiologically associated with hospitalized lower respira-
tory tract illness among children. Among adults, HRV-A and
HRV-C detections were more common among hospitalized adults
with lower respiratory illness compared to controls, however, the
risk measurements were not statistically significant, likely due to
small numbers after stratification by species. Unlike other reports
in the literature [1,2,16], we were unable to demonstrate that
HRV-C was associated with more severe illness compared to other
HRV species. HRV-A was the most commonly detected species
among hospitalized adults and infants ,1 year of age but HRV-C
was the most common detected species among children aged 1–18
years. Our results differ from a recently publicized study of
hospitalized children aged ,5 years in Thailand that reported
HRV-C as more common than HRV-A among children in all age
groups during 2007 [30]. Studies with larger cohorts might
provide additional insight into these observations. Also, additional
methods to differentiate HRV, in addition to species, may help
further characterize them and the illness associated with them.
Among hospitalized enrolled adults aged .50 years with lower
respiratory tract illness in SaKaeo province, the rate of HRV
detections with and without co-detection of another pathogen was
high, second only to influenza viruses [23]. Hospitalized adults
were 4-fold more likely to have HRV detected compared to
controls; less than five percent of control adults had HRV
detections. In addition, the rates of HRV detection among adults
$50 years of age with radiographically-confirmed pneumonia
with and without co-detection of another pathogen were similar to
rates for detection of influenza viruses and S. pneumonia [23].
Approximately, 8% of radiographically-confirmed pneumonias
among adults $20 years of age were associated with HRV
detection (without another pathogen detected). Our HRV
detection results are similar to those reported from a one year
cohort study of hospitalized adults with community-acquired
pneumonia in New Zealand [12]. Also, several reports have found
an association with HRV detection and asthma exacerbation
[5,14,22,31]. Thus, treatment or prevention modalities for HRV
might reduce the significant morbidity associated with HRV-
associated asthma and adult lower respiratory tract hospitalization.
We estimated high rates of HRV detections among children ,5
years of age. However, this age group also had a high frequency of
HRV detections among young control children without respira-
tory symptoms or fever. Thus, our rates may not reflect the actual
burden of HRV-associated illness among hospitalized pediatric
patients; we cannot differentiate those children who were
hospitalized with HRV-associated illness versus those that may
not have had symptoms due to HRV despite HRV shedding.
Several reports suggest that young children shed HRVs for more
than one week [19,20,22]. Therefore, it is possible that HRV
detection among ill or non-ill children might be from a previous
illness. We did not ask controls about illness more than three days
previously or follow them to see if they became ill, and no
hospitalized patients were asked about prior illness unrelated to the
hospitalization. Also, the presence of rhinorrhea was not an
exclusion criterion for controls and was not recorded; recording
rhinorrhea and previous history of illness would improve the useful
of this type of control. Thus, while patients with HRV detections
were associated with hospitalized lower respiratory tract illness, it
is not possible to determine the actual number or burden of HRV-
associated illnesses among pediatric patients. Additional studies,
especially those with a longitudinally followed cohort, are needed
to better characterize HRV-associated illness among hospitalized
children.
Almost half of the hospitalized children with HRV detection
and up to a third of hospitalized adults with HRV detection had
co-detection of another respiratory pathogen. These proportions
are similar to other reports [4]. In addition, previously we reported
Table 5. Comparison of HRV detections among hospitalized
enrolled patients and controls, Sa Kaeo Province, Thailand,
September 1, 2004–August 31, 2005.
Hospitalized
No./No. (%)
Controls
No./No. (%)
Adjusted* OR
(95% CI)
Adults $19 years
All HRV detections 68/673 (10) 3/128 (2.3) 4.8 (1.5, 15.8)
£
Excluding co-
detections**
54/577 (9.4) 3/128 (2.3) 4.4 (1.3, 14.4)
£
HRV-A 31/673 (4.6) 1/128 (0.8) 6.2 (0.8, 46.2)
Excluding co-
detections**
25/577 (4.3) 1/128 (0.8) 5.6 (0.7, 42.4)
HRV-B 19/673 (2.8) 1/128 (0.8) 3.7 (0.5, 28.4)
Excluding co-
detections**
14/577 (2.4) 1/128 (0.8) 3.0 (0.4, 23.6)
HRV-C 15/673 (2.2) 1/128 (0.8) 3.2 (0.4, 24.5)
Excluding co-
detections**
12/577 (2.1) 1/128 (0.8) 3.0 (0.4, 23.6)
Children ,19 years
All HRV detections 130/501 (26) 24/152 (16) 2.0 (1.2, 3.3)
£
Excluding co-
detections**
78/322 (24) 22/150 (15) 2.1 (1.2, 3.6)
£
HRV-A 49/501 (10) 10/152 (6.6) 1.7 (0.8, 3.5)
Excluding co-
detections**
31/322 (10) 8/150 (5.3) 2.3 (1.0, 5.3)
£
HRV-B 7/501 (1.4) 4/152 (2.6) 0.5 (0.1, 1.8)
Excluding co-
detections**
6/322 (1.9) 4/140 (2.7) 0.7 (0.2, 2.7)
HRV-C 58/501 (12) 8/152 (5.3) 2.7 (1.2, 5.9)
£
Excluding co-
detections**
37/322 (11) 8/150 (5.3) 2.4 (1.0, 5.5)
£
HRV=human rhinovirus, OR=odds ratio, CI=confidence interval.
*Adjusted for month of detection.
£P#.05.
**Co-detections included RSV, HMPV, HPIV 1–3, influenza type A or B, and
adenovirus for all patients, and S. pneumoniae for hospitalized adults aged $18
years. During the first study year, co-detections with Mycoplasma, Chlamydia,
and Legionella were included for hospitalized patients.
doi:10.1371/journal.pone.0017780.t005
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during the second study year [32,33] but did not include them in
this analysis due to their uncertain association with hospitalized
illness. Our results support the identification, and probable
exclusion, of infection with other known respiratory pathogens
as important for evaluating illness possibly associated with HRV.
Our results are limited by some potential biases. We did not
enroll hospitalized patients who met the clinical case definition for
acute lower respiratory illness but did not have a chest radiograph
ordered within 48 hours of admission or who presented with other
clinicalsyndromes,includingthosewithexacerbationsofunderlying
disease. Patients with acute lower respiratory illness who did not get
a chest radiograph tended to be younger and possibly less seriously
ill (i.e., fewer intubations and fatalities) (HC Baggett, person.
comm.). Some patients with acute lower respiratory illness who did
not get a chest radiograph may have had illness due to HRV; thus,
our incidenceestimates for hospitalized HRV-associated illnessmay
be underestimated. Although only 45% of eligible patients were
enrolled, we found few differences in clinical characteristics between
those who were enrolled compared to those who were not enrolled.
However, young children and those in the intensive care unit were
less likely to enroll in the etiology study (HC Baggett, person.
comm.). Our study results may not be representative of all young
children and seriously ill. Also, we were able to test for limited
bacterial co-detections among children and did not have blood
cultures. In addition, we only tested for atypical bacteria during one
year. Thus, we likely missed some bacterial co-detections. Finally,
our outpatient sample was a convenience sample and may not be
representative of the population in Sa Kaeo Province; few adults
were enrolled in the outpatient setting with influenza-like illness.
We present evidence for HRVs, and HRV-A and HRV-C, as
pathogens associated with hospitalized respiratory illness and as a
virus detected when there was no direct connection with illness
(i.e., bystander virus). Among adults and children in rural
Thailand, HRVs were associated with a substantial burden of
hospitalized lower respiratory tract illness. While further studies
are needed to characterize the true burden of HRV-associated
pediatric hospitalizations, new treatment or prevention modalities
effective against HRV would likely reduce what appears to be a
substantial morbidity associated with HRV-associated illness.
Figure 1. Seasonality of HRV detections among enrolled hospitalized patients and outpatients with influenza-like illness, Sa Kaeo
Province, Sept 1, 2003–Aug 31, 2005.
doi:10.1371/journal.pone.0017780.g001
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